way to increase hGH levels was through prescription injections. The problem with these injections is that they're extremely expensive (costs can run as high as $1500 per month), and highly controversial… some experts argue against the use of these synthetic injections because they fear introducing synthetic hGH into the body may upset natural hGH production.
"That's what makes SeroVital so revolutionary," says Dr. Amy Heaton, PhD, Director of Scientific Affairs for SanMedica International™, SeroVital's distributor. "Rather than introducing synthetic hGH into the body via injections, SeroVital increases the body's own, endogenous levels of human growth hormone by promoting pituitary health. SeroVital not only provides a more affordable way for people to raise their hGH levels, but does so in a clinically proven way that allows users to achieve this naturally and without the risks associated with injections."
Still, some skeptics are saying SeroVital sounds too good to be true. So is there a catch? Well, there are three. First, as with HGH injections, SeroVital is not a "magic bullet," but one part of a healthy lifestyle choice including a sensible diet and exercise regimen.
Second, for proper absorption, you have to take SeroVital-hgh on an empty stomach. That means you either have to take it first thing in the morning and then not eat anything for two hours, or take it at night, at least two hours after your last meal... before you go to bed.
And last but not least, while SeroVital is far less expensive than prescription HGH injections, it's still not cheap... SeroVital will cost you about $100 a month.
But is it worth it? To most people, anything that may reduce wrinkles, tighten saggy skin, decrease body fat, increase lean muscle mass, strengthen bones, and boost mood, while giving you plenty of energy, improving your sex drive and helping you sleep better is a no-brainer. However, makPage: 1 2 3 4 Related medicine technology :1
. "Miracle" Medical Device Saves Teen from Lifetime on Ventilator2
. Ambrx and Zhejiang Medicine Co. Ltd. Form Collaboration to Develop and Commercialize Ambrxs Antibody Drug Conjugate for Breast Cancer3
. Supreme Court Ruling Today Allows DNATraits to Offer Low Cost BRCA Breast and Ovarian Cancer Gene Testing in U.S.4
. ASCO Interview of MD Andersons Mittendorf on AE37 Breast Cancer Vaccine Now Available on Generex Websites5
. Generex Announces Interview of MD Andersons Dr. Elizabeth Mittendorf, Principal Investigator on Companys AE37 Phase IIb Breast Cancer Efficacy Trial6
. Tumor Immunotherapy Efficacy Increased in Both Breast and Prostate Cancer Preclinical Models with Addition of Galectin Inhibitor7
. Generex Announces ASCO Presentations of AE37 Vaccine Data; Potential Leading Immunotherapy Option for Breast Cancer Patients8
. Nektar Presents Target-Specific Biomarkers Being Assessed in Ongoing Phase 3 BEACON Study of Etirinotecan Pegol for the Treatment of Metastatic Breast Cancer at the 2013 American Society of Clinical Oncology Annual Meeting9
. Ground-breaking Research Identifies Molecular Subtyping as a Key to Determining Prognosis and Benefit of Chemotherapy for Breast and Colorectal Cancers10
. Genomic Health Announces Results of Ten Studies in Breast, Prostate and Colon Cancers at the American Society of Clinical Oncology (ASCO) Annual Meeting11
. Breast Cancer Imaging Market: US, EU, South America Analysis & Forecast Research Reports